Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solitary Fibrous Tumors × Trabectedin × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 14 Ovarian Neoplasms 6 Liposarcoma 5 Leiomyosarcoma 5 Neoplasms 4 Liposarcoma, Myxoid 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Ichthyosis, X-Linked 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Solitary Fibrous Tumors 1 Soft Tissue Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Recurrent High Grade Meningioma 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms by Site 1 Mesothelioma 1 Malignant mesenchymal tumor 1 Leiomyosarcoma Uterus 1

Interventions

pazopanib 1 eribulin 1 Trabectedin 1 Doxorubicin 1 Dasatinib 1 Dacarbazine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03023124 2024-12-09

STRADA

Italian Sarcoma Group

Phase 2 Completed

Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡